Blood Safety (Transfusion)

Soluble VEGF Is Present in Blood Components

Published in Blood Weekly, November 8th, 1999

by Cathy Clark, Senior Editor -- Soluble vascular endothelial growth factor is present in blood components, depending on the duration of storage.

Blood transfusion may diminish survival following curative surgery for solid tumors. This may be related to extracellular content of cancer growth factors present in the transfusion components. VEGF is a potent stimulator of angiogenesis in solid tumors.

Hans Jorgen Nielsen, of Denmark's University of Copenhagen, and colleagues performed a study to determine the potential content of soluble vascular endothelial growth factor (sVEGF) in various blood components for transfusion ("Soluble Vascular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1999-11-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry